Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Jun 23, 2026 Life Science
Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Jun 22, 2026 Life Science
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race Jun 16, 2026 Life Science
The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration Jun 12, 2026 Life Science
RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough Jun 11, 2026 Life Science
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year Jun 11, 2026 Life Science
Market Embraces R&D Pipeline Progress, Moderna’s Stock Soars on Cancer Vaccine Prospects Jun 9, 2026 Life Science
The Economic Outlook Clouds Over, Weighing on the Market, but Two Pharmaceutical Giants May Buck the Trend Jun 8, 2026 Life Science
Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion Jun 8, 2026 Life Science
